Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wuziyanzong pills versus levocarnitine for asthenospermia
ChiCTR2300072563Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Wuzi Yanzong Pill in asthenospermia (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Percentage of sperm forward movement. Started Oct 2022; status: recruiting.
02
Drugs
Wuzi Yanzong Pill
03
Conditions
asthenospermia
Beyond the preview
Go deeper on ChiCTR2300072563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072563.